DIETARY COMPOSITIONS CONTAINING ALPHA AMINO N-BUTYRATE AND METHODS OF ENHANCING LEAN BODY MASS

• US 20080242727A1
• Filed: 03/27/2008
• Published: 10/02/2008
• Est. Priority Date: 03/27/2007
• Status: Abandoned Application

• Current Assignee: Peter Miller, Tim Romero
• Original Assignee: Peter Miller, Tim Romero
• Inventors: Miller, Peter, Romero, Tim
• Application Number:
  US12/056,662
• Publication Number:
  US 20080242727A1
• Time in Patent Office: Days
• US Class Current: 514/561
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 31/164 of a carboxylic acid with an aminoalcohol, e.g. ceramides
• CPC Class Codes: A61K 31/198 Alpha-amino acids, e.g. alanine or edetic acid [EDTA] betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00
• CPC Class Codes: A61K 45/06 Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• CPC Class Codes: A61P 21/00 Drugs for disorders of the muscular or neuromuscular system

Abstract

A composition that may include branched chain amino acids, alpha amino n-Butyrate and/or alpha amino-n-valerate works synergistically to enhance lean body mass and prevent body mass breakdown. The composition may also be coupled with other agents to a) provide an increased level of amino acids and/or protein in the body'"'"'s total pool or b) increase markers for protein translation or decrease markers of protein turnover. The composition may be administered in a variety of ways including capsules, tablets, powdered beverages, bars, gels or drinks. Increasing lean body mass is import to athletes looking to enhance performance, in the event of certain muscle wasting diseases, and to the general population that loses muscle mass as it ages.

Claims

1. A composition comprising alpha amino-n butyrate, alpha amino-n-valerate, or a combination of alpha amino-n butyrate and alpha amino-n-valerate.

2. The composition of claim 1, further comprising a branched chain amino acid.

3. The composition of claim 2, wherein the branched chain amino acid is selected from a group consisting of Leucine, Isoleucine and Valine.

4. The composition of claim 2, wherein the molar ratio of the branched chain amino acid and alpha amino n-butryate is selected from a group consisting of:

1;

1 and 2;

1.

5. The composition of claim 2, wherein the molar ratio of the branched chain amino acid and alpha amino n-valerate is selected from a group consisting of:

1;

1 and 2;

1.

6. The composition of claim 2, wherein the branched chain amino acid comprises a salt or other derivate.

7. The composition according to claim 1 wherein the composition is a salt or other derivate of alpha amino n-butyrate or alpha-amino-N-valerate.

8. The composition according to claim 1, wherein the composition is an ester or ether derivate of alpha amino n-butyrate or alpha-amino N-valerate.

9. A composition according to claim 2, wherein the composition is an ester or ether derivate of the branched chain amino acid.

10. The composition of claim 2, further comprising an agent selected from a group consisting of creatine, glutamine, threonine, methionine, tyrosine and alanine.

12. The method of claim 10, wherein the composition further comprises a therapeutically effective amount of a branched chain amino acid or derivative thereof.

13. The method of claim 10, wherein the therapeutically effective amount of the alpha amino n-butryate or a salt, ether, ester or derivative thereof comprises 0.01-100 mg/kg bodyweight.

14. The method of claim 10, wherein the therapeutically effective amount of the alpha-amino n-valerate or a salt, ether, ester or derivative thereof comprises 0.01-100 mg/kg bodyweight.

15. The method of claim 10, wherein the therapeutically effective amount of the branched chain amino acid or derivative thereof comprises 0.01-100 mg/kg bodyweight.

17. The composition of claim 15 further consisting essentially of a branched chain amino acid.

19. The composition of claim 14, wherein the molar ratio of the branched chain amino acid and alpha amino n-butryate is selected from a group consisting of:

1;

1 and 2;

1.

20. The composition of claim 14, wherein the molar ratio of the branched chain amino acid and alpha amino n-valerate is selected from a group consisting of:

1;

1 and 2;

1.

11. The method for increasing lean body mass and preserving muscle mass in a mammal comprising the steps of orally administering a therapeutically effective amount of a composition comprising alpha amino n-butryate or a salt, ether, ester or derivative thereof and alpha-amino n-valerate or a salt, ether, ester or derivative thereof.

16. A composition increasing lean body mass and preserving muscle mass including at least one of a consisting essentially of an alpha amino-n butyrate or an alpha amino-n-valerate.

18. The composition of claim 16, wherein the branched chain amino acid is selected from a group consisting of Leucine, Isoleucine and Valine.